J Gynecol Oncol.
2019 Nov;30(6):e113. 10.3802/jgo.2019.30.e113.
Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
- Affiliations
-
- 1Department of Obstetrics and Gynecology, Tokai University School of Medicine, Kanagawa, Japan. mmikami@is.icc.u-tokai.ac.jp
- 2Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA.
- 3Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
- 4Department of Obstetrics and Gynecology, Niigata University School of Medicine, Niigata, Japan.
- KMID: 2458909
- DOI: http://doi.org/10.3802/jgo.2019.30.e113
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology
- Role of lymphadenectomy for ovarian cancer
- Advanced ovarian cancer: what should be the standard of care?
- Chemotherapy for ovarian cancer
- Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer
